. . . "4141-4147" . . "1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor o"@en . . . "Robert M Knabb" . . "Ming Y He" . "16" . "Angela Smallwood" . . . "Richard S Alexander" . "1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor o"@en . "\u043D\u0430\u0443\u043A\u043E\u0432\u0430 \u0441\u0442\u0430\u0442\u0442\u044F, \u043E\u043F\u0443\u0431\u043B\u0456\u043A\u043E\u0432\u0430\u043D\u0430 \u0432 \u0442\u0440\u0430\u0432\u043D\u0456 2006"@uk . "Michael J Orwat" . . . "Alan R Rendina" . "1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor o"@nl . "15" . . "Pancras C Wong" . . "art\u00EDculu cient\u00EDficu espubliz\u00E1u en mayu de 2006"@ast . "scientific article published on 30 May 2006"@en . . "10.1016/J.BMCL.2006.02.069" . . "Steven Bai" . "Kan He" . "16730984" . "Qi Han" . "Lawrence Mersinger" . "1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor of blood coagulation factor Xa"@en . . "1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor o"@nl . "2006-05-30T00:00:00Z"^^ . "Donald J P Pinto" . . . . "Mimi L Quan" . "Karen A Rossi" . . "1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor o"@nl . "Robert A Galemmo" . . "Ruth R Wexler" . . . . . "Charles Kettner" . . "im Mai 2006 ver\u00F6ffentlichter wissenschaftlicher Artikel"@de . . . . . . "Joseph M Luettgen" . "1-[3-Aminobenzisoxazol-5'-yl]-3-trifluoromethyl-6-[2'-(3-(R)-hydroxy-N-pyrrolidinyl)methyl-[1,1']-biphen-4-yl]-1,4,5,6-tetrahydropyrazolo-[3,4-c]-pyridin-7-one (BMS-740808) a highly potent, selective, efficacious, and orally bioavailable inhibitor o"@en . . "wetenschappelijk artikel"@nl . . "article scientifique publi\u00E9 en 2006"@fr . "Brian Wells" . . . "Patrick Y S Lam" . . . "Eugene Amparo" .